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Abstract
Poly-3-hydroxyalkanoates PHAs are synthesized by many bacteria as intracellular storage material. The ﬁnal
step in PHA biosynthesis is catalyzed by two PHA polymerases phaC in Pseudomonas putida. The expression
of these two phaC genes phaC1 and phaC2 was studied in Escherichia coli, either under control of the native
promoter or under control of an external promoter. It was found that the two phaC genes are not expressed in E.
coli without an external promoter. During heterologous expression of phaC from Plac on a high copy number
plasmid, a rapid reduction of the number of colony forming units was observed, especially for phaC2. It appears
that the plasmid instability was partially caused by high-level production of PHA polymerase. Subsequently,
tightly regulated phaC2 expression systems on a low copy number vector were applied in E. coli. This resulted in
PHA yields of over 20% of total cell dry weight, which was 2 fold higher than that obtained from the system
where phaC2 is present on a high copy number vector. In addition, the PHA monomer composition differed
when different gene expression systems or different phaC genes were applied.
Introduction
Medium chain length poly-3-hydroxyalkanoates
mcl-PHAs accumulated by various bacteria are of
increasing industrial interest because of their broad
range of potential applications such as biodegradable
plastics Hänggi 1995; Page 1995, crosslinked bio-
degradable rubbers de Koning and Witholt 1996,
materials in medicine and pharmacy industries Wil-
liams et al. 1999, and sources of chiral monomers
Hrabak 1992. These biodegradable polymers can be
produced from renewable substrates and therefore
have the potential to replace chemically synthesized
polymers, provided that the physiology, genetics, and
biochemistry of the PHA-producing organisms are
better understood.
Mcl-PHAs were ﬁrst identiﬁed in Pseudomonas
putida Gpo1 earlier known as Pseudomonas oleo-
vorans grown on n-octane and other alkanes de
Smet et al. 1983; van Beilen et al. 2001. It has been
reported that the pha locus from P. putida GPo1 en-
codes two PHA polymerases and a depolymerase
Figure 1 Huisman et al. 1991. The substrate
speciﬁcities of these enzymes differ slightly Huis-
man et al. 1992. The two PHA polymerases are 53%
identical. A homologous operon from P. aeruginosa
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has also been identiﬁed Timm and Steinbüchel
1992. The corresponding PHA polymerases from P.
putida and P. aeruginosa show 69-80% identity at
amino acid level Huisman et al. 1991; Timm and
Steinbüchel 1992.
Biosynthesis of these polymers in host organisms
that do not naturally produce PHA allows modiﬁca-
tion of biosynthetic enzymes. This in turn allows in-
creases in the quantity and quality of the products
Kidwell et al. 1995. In addition, introduction of
speciﬁc genes into an organism having a suitably
modiﬁed PHA synthetic pathway may allow exten-
sion and regulation of the range of compounds that is
produced. Escherichia coli is one of these useful
hosts. Indeed, many peptides and proteins of pharma-
ceutical value have been successfully expressed in
recombinant E. coli. Mcl-PHA has also been success-
fully produced in E. coli by using P. aeruginosa phaC
genes Langenbach et al. 1997; Qi et al. 1997 and P.
putida GPo1 phaC genes Ren 1997; Ren et al.
2000a; Ren et al. 2000b expressed from the Plac
promoter. However, there are no reports on the sta-
bility and sustainability of heterologous phaC expres-
sion systems or high-copy-number plasmids in
recombinant E. coli, even though large-scale PHA
production requires stable and constant expression of
phaC genes.
In this study, we compared expression of the two
phaC genes from P. putida in E. coli recombinants,
and investigated the stability of different phaC
expression systems. Our results demonstrated that the
two phaC genes cannot be expressed without an ex-
ternal promoter in E. coli. Stable and regulated ex-
pression of phaC genes resulted in the formation of
about 20% PHA of total cell dry weight during batch
cultivation. Slight differences in the composition of
PHA produced with either PhaC1 or PhaC2 were ob-
served. These stable, regulated systems for phaC gene
expressions can serve as a ﬁrst step toward establish-
ing PHA production in recombinant strains.
Materials and methods
Strains and plasmids. E. coli fadRfadB strain
JMU193 Rhie and Dennis 1995 and P. putida
GPp104 Huisman et al. 1991 were used throughout.
Plasmids pGEc407 Huisman et al. 1991, pGEc404
Huisman et al. 1991, pJRD215 Davison et al.
1987, pGEM-7 Promega, pMMB24 Bagdasar-
ian et al. 1983, pVLT33/35 de Lorenzo et al. 1993,
pCNB5 de Lorenzo et al. 1993, pBCKS Promega,
and pUC18/19 Yanisch-Perron et al. 1985 were used
to construct the plasmids listed in Figure 2. Plasmids
Figure 1. Organization of the pha genes. The scheme not to scale summarizes the organisation of the pha locus of P. putida Gpo1 con-
taining at least four open reading frames ORFs Huisman et al. 1991. Two polymerases and one depolymerase are encoded by phaC1,
phaC2 and phaZ genes, respectively. The phaD gene may encode a granule associated protein van der Leij and Witholt 1995. Possible
promoters are indicated with P. The transcriptional directions are indicated by arrows. The upper and lower parts of the Figure represent
expansion of the upstream regions of phaC1 and phaC2. The square boxes indicate the start codon. The ribosome binding site RBS is
underlined. bp, base pair.
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were introduced into JMU193 according to standard
procedures Sambrook et al. 1989.
Recombinant DNA techniques. All general DNA
manipulations were performed as previously de-
scribed Sambrook et al. 1989. Transformations of E.
coli competent cells were carried out according to
standard procedures Sambrook et al. 1989.
Construction of pBTC1 and pBTC2 (Figure 2).
pET101 was obtained by inserting the EcoRI-PstI
phaC1 fragment from pGEc407 in pUC18. pET101
was then cut with EcoRI and HindIII to obtain a 2.2
kb fragment, which was cloned into the EcoRI and
HindIII site of pJRD215, resulting in pET1 Figure
2, or inserted into pVLT33, resulting in pBTC1.
pET104 Ren et al. 2000a and pET103 contain a
Figure 2. Schematic representation of the strategy to construct plasmids used in this study. Only the relevant cloned genes and restriction
sites are shown. See Materials & Methods for further details.
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Figure 2. Continued.
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HindIII-SphI fragment with phaC2 from pGEc404 in
pUC19 and pUC18, respectively. pET105 was de-
rived from pET104 by inserting an EcoRI excised la-
cIq gene from pCNB5 into pET104. pET2 was
obtained by inserting the EcoRI-HindIII fragment
with phaC2 from pET103 into pJRD215. pBTC2’
Ren et al. 2000a was obtained by inserting BamHI-
HindII fragment of pET104 into pBCKS. pBTC2
Ren et al. 2000a contains the HindIII-BamHI frag-
ment with phaC2 from pBTC2’ in pVLT35.
Construction of pET2. pMMB24 was cut with
HindIII to obtain the transcriptional terminator ,
which was then inserted into HindIII digested pET2,
resulting in pET2.
Media and culture conditions. E. coli was
precultured at 37 °C in Luria-Bertani LB medium
Sambrook et al. 1989, then transferred with 1:100
dilution to 0.1NE2 Huisman et al. 1989 minimal
medium containing 2 mM hexadecanoate and 0.2%
yeast extract as co-carbon source. Hexadecanoate
stock solutions were prepared as previously described
Jenkins and Nunn 1987. If necessary, antibiotics
were added: kanamycin Km, 50 g/ml, ampicillin
Ap, 150 g/ml, streptomycin Sp, 50 g/ml,
chloramphenicol Cm, 30 g/ml. Cell growth was
monitored by measuring optical density at 450 nm
OD450 Witholt 1972. In order to induce the Plac
or Ptac promoter, isopropyl--D-thiogalactopyrano-
side IPTG was added to indicated concentrations in
the early exponential phase OD450 about 0.2.
Samples were taken as described in the results sec-
tion.
Plasmid stability. To determine the percentage of
cells that lost plasmids carrying the ampicillin, strep-
tomycin or kanamycin resistance, cells were serially
diluted and plated on LB plates with and without 150
g/ml Ap, 50 g/ml Sp or 50 g/ml Km. The num-
ber of colonies was counted after overnight growth,
and compared.
Determination of PHA. To determine the polyes-
ter content of bacteria, cells were grown in minimal
medium cultures as indicated in the results section
and assayed for the presence and composition of PHA
by gas chromatography GC Lageveen et al. 1988.
All experiments were carried out 2 or 3 times, and
averages of these independent experiments are
presented.
Results and discussion
Previously we have reported that deﬁciency of the
fatty acid degradation enzymes FadA or FadB
enabled mcl-PHA synthesis in E. coli Ren et al.
Figure 3. Stability of phaC containing plasmids in E. coli. E. coli recombinants JMU193 carrying pET101, pET104, pET105, pBTC1 and
pBTC2 were grown on minimal media containing 2 mM hexadecanoate and 0.2% yeast extract with relevant antibiotics ampicillin or kana-
mycin. Colony forming units were then monitored for 36 h.
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2000a. In this study, the E. coli fadR fadB mutant
JMU193 was used. The fadR gene encodes a protein
that exerts negative control over genes necessary for
fatty acid oxidation Black and DiRusso 1994;
DiRusso and Nunn 1985; Jenkins and Nunn 1987;
Nunn 1986. A mutation in fadR derepresses tran-
scription of these genes, as a result of which the fad
genes are constitutively expressed, rendering E. coli
capable of growth on mcl fatty acids Black and Di-
Russo 1994; DiRusso and Nunn 1985. The fadB gene
encodes four enzyme activities of the fatty acid oxi-
dation path: enoyl-CoA hydratase, 3-hydroxyacyl-
CoA dehydrogenase, 3-cis-2-trans-enoyl-CoA
isomerase, and 3-hydroxyacyl-CoA epimerase Black
and DiRusso 1994; DiRusso and Nunn 1985; Jenkins
and Nunn 1987; Nunn 1986. Mutations in fadB block
fatty acid oxidation and result in the accumulation of
speciﬁc intermediates, which can be channeled to
PHA formation Ren et al. 2000a.
PhaC1 and phaC2 expression plasmids. To better
understand the consequences of regulated or unregu-
lated phaC1 and phaC2 expression from their native
or heterologous promoters in E. coli, we constructed
the plasmids listed in Table 1. Plasmid pET1 contains
the native, unmodiﬁed phaC1 gene plus the upstream
region up to  555 bp with respect to the ATG start
codon without external promoter Figure 1. pET2
contains phaC2 plus the upstream region up to
 120 bp with respect to the ATG start codon with-
out external promoter Figure 1. pET101 and
pET104 contain phaC1 and phaC2, respectively, with
upstream regions and the genes are expressed from
the Plac promoter Table 1.
Expression of phaC genes and PHA formation in
pha+ E. coli. E. coli JMU193 was transformed with
the plasmids described above. The transformants
were cultivated in minimal medium containing 2 mM
hexadecanoate and 0.2% yeast extract as described in
‘Material and methods‘ and samples were analysed
for PHA accumulation after 48 h. In E. coli
JMU193pET1, no trace of any of the methyl esters
of 3-hydroxyalkanoates  0.1% PHA of cell dry
weight was found Table 1, whereas in E. coli
JMU193 harbouring pET101, a high copy number
plasmid through which phaC1 is constitutively
expressed from the Plac promoter i. e. the Plac pro-
moter is not controlled by the monocopy lacI prod-
uct, PHA accumulated to about 26% of the cellular
dry matter Table 1. Therefore, we conclude that the
promoter of phaC1 from P. putida GPo1 is not active
in E. coli.
In E. coli JMU193 harbouring pET2, about 5%
PHA of total cell dry weight was produced Table 1,
suggesting that a promoter upstream of phaC2 is ac-
tive in E. coli. To test this possibility, a transcriptional
terminator was inserted into the polylinker region
 555 bp upstream of phaC2 in pET2, resulting in
pET2 Table 1. No detectable PHA was found in
E. coli JMU193 carrying pET2. Thus, phaC2 is not
expressed in E. coli without an external promoter. The
reason why 5% PHA was found in JMU193 carrying
pET2 could be that a putative foreign promoter such
as promoters for antibiotics resistances upstream of
phaC2 is present on pET2, in other words, the
expression of phaC2 on pET2 in E. coli is not driven
by its native promoter but by a putative foreign pro-
moter upstream of phaC2. Compared with pET2,
pET1 did not lead to PHA production in recombinant
E. coli, even though both phaC1 from pET1 and
phaC2 from pET2 are located on the same plasmid.
This could be caused by the reversed orientation of
the two genes on the plasmid, resulting in that phaC2
could be expressed by a putative foreign promoter,
whereas phaC1 could not. When E. coli JMU193
harbouring pET104 constitutive phaC2 expression
from the Plac promoter was tested, about 1.2% PHA
was formed Table 1.
Since each of the phaC genes from P. putida Gpo1
enables PHA synthesis in the PHA negative mutant P.
putida GPp104, both genes are likely to have a simi-
lar function in the formation of PHA Huisman et al.
1992, Huisman et al. 1991. It has been shown that
there is an active promoter upstream of phaC1 in P.
putida Huisman et al. 1991. A promoter upstream
of phaC2 has also been postulated for P. aeruginosa
PAO1 Timm and Steinbüchel 1992. Furthermore,
expression of pET2 in P. putida GPp104 resulted in
a PHA accumulation of 9.4% of the total cell dry
weight, thereby proving the presence of an active
promoter upstream of the phaC2 gene. However, our
results demonstrate that these two promoters are not
active in E. coli. This is different from the well stud-
ied PHB synthetic genes, which are constitutively ex-
pressed from their own promoter in E. coli Schubert
et al. 1991. Since expression of many Pseudomonas
genes is positively regulated, and these genes are not
transcribed without the corresponding regulatory pro-
tein in E. coli Deretic et al. 1989, our data indicates
that not only the transcription of phaC1 is regulated
in P. putida GPo1, as reported previously Prieto et
al. 1999, but also probably that of phaC2. However,
we cannot rule out other possibilities for the failure
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to obtain phaC2 expression in E. coli, such as that the
phaC2 promoter is not recognised by the E. coli RNA
polymerase.
Plasmid stability in E. coli recombinants ex-
pressing phaC. One possible reason for the lower
amount of PHA associated with the high gene dosage
in JMU193pET104 compared to that in
JMU193pET2 could be the loss of the plasmid.
Therefore, we investigated the stability of the
constructed plasmids. To determine the percentage of
cells that lost the antibiotic resistance, the JMU193
recombinants were grown in batch cultures in mini-
mal media supplied with 2 mM hexadecanoate and
0.2% yeast extract in the presence of the selective
marker JMU193 carrying pET101 or pET104 with
ampicillin, JMU193 carrying pET1 or pET2 with
kanamycin, and the antibiotic resistance was moni-
tored for approximately 36 h. Cultures were serially
Table 1. PHAs produced in E. coli JMU193 carrying different phaC expression plasmids
Plasmidsa Structureb Vecorsb PHA%c Monomer compositiond
C6 C8 C10
pET1 pJRD215  0.1 – – –
pET101 pUC18 25.8 10 76 14
pBTC1* pVLT33 17.3 11 78 11
pET2 pJRD215 4.8 6 88 6
pET2 pJRD215  0.1 – – –
pET104 pUC19 1.2 – – –
pET105* pUC19 10.8 7 76 17
pBTC2* pVLT35 20.4 8 77 15
aE. coli recombinants were grown on 0.1NE2 with 2 mM hexadecanoate and 0.2% yeast extract. Samples were analyzed for PHA after 48 h.
*, induced with 100 M or high up to 1 mM IPTG at early exponential phase; bpJRD215 low copy number, pVLT33/35 low copy number
and pUC18/19 high copy number derived plasmids contain the phaC1 or phaC2 gene of P. putida GPo1 in orientations indicated by open
arrows. The solid arrows represent the direction of the heterologous Plac or Ptac promoter; cThe amount of PHA is given as percentage of
cell dry weight cdw; dThe monomer composition is given as molar percentage. C6, 3-hydroxyhexanoate; C8, 3-hydroxyoctanoate; C10,
3-hydroxydecanoate.
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diluted and plated on LB plates with and without 150
g/ml ampicillin or 50 g/ml kanamycin. The num-
ber of colonies was counted after overnight growth
and compared. Plasmids pET1 and pET2 were 100%
stable in JMU193 during the tested time period data
not shown. However, the presence of these plasmids
in JMU193 resulted in no or low PHA production
Table 1. Figure 3 shows that in the
JMU193pET104 culture, 60% of the cells lost the
ampicillin resistance within 10 h; while in the
JMU193pET101 culture, 89% of the cells remained
ampicillin resistant after 10 h. The above results re-
veal that although both phaC1 in pET101 and
phaC2 in pET104 were cloned in the same high
copy number plasmid and equipped with the same
strong promoter Table 1, the latter is less stable in
E. coli JMU193 Figure 3. This difference is prob-
ably caused by the different upstream regions of
phaC1 in pET101 and phaC2 in pET104 Figure 1,
or by the nature of the expressed protein.
To test whether uncontrolled expression of phaC2
from pET104 plays a role in the plasmid instability,
we constructed pET105 from pET104 Table 1.
pET105 overproduces the LacI repressor protein to
control the expression of phaC2. Under induced con-
ditions, about 77% of the JMU193pET105 cells re-
mained ampicillin resistant after 10 h growth in
minimal media batch culture with hexadecanoate and
yeast extract in the presence of ampicillin Figure 3.
To quantify the PHA content, JMU193pET105 was
cultivated on 0.1NE2 minimal medium with hexade-
canoate and yeast extract as described in ‘Materials
and Methods‘. About 11% PHA relative to cell dry
weight was obtained from JMU193pET105 after 48
h Table 1, whereas less than 0.1% PHA was found
without induction. Therefore, we conclude that
uncontrolled overproduction of PHA polymerase in
JMU103pET104 is at least in part responsible for
the observed low amount PHA. Regulated expression
of phaC2 from pET105 enhanced plasmid stability,
which led to enhanced PHA accumulation. The loss
of the PHA accumulation phenotype is possibly
caused by the segregational instability of pET104 in
E. coli JMU193, which could be further increased by
the uncontrolled expression of phaC2 from the strong
heterologous Plac promoter on a high copy number
vector: overproduction of PhaC2 might be toxic to E.
coli cells. Subsequently, plasmid-free cells grew
faster, allowing them to overgrow the recombinant
cell population. This hypothesis was conﬁrmed by
using pET105. Although pET105 is also not com-
pletely stable in E. coli JMU193 77% of the cells still
contained plasmid after 10 hours, the increased sta-
bility compared to pET104 already allowed E. coli
JMU193 to synthesize about 11% PHA upon IPTG
induction.
Another reason for the instability of pET101,
pET104 and pET105 in JMU193 could be the insta-
bility of ampicillin which is degraded in time by E.
coli cells Sambrook et al. 1989.
Application of stable plasmids in recombinant
E. coli. The results described above show that the
high copy number plasmids pET101, pET105 and
pET104, all with ampicillin markers, were not stable
enough for PHA production. This suggests that the
combination of controlled phaC expression from a
strong heterologous promoter on low copy number
plasmid with another antibiotic marker might be ef-
fective in stabilizing PHA production in E. coli.
Therefore, we constructed pBTC1 and pBTC2 Fig-
ure 2, which are derived from a low copy number
vector containing the Ptac promoter, a lacIq gene, and
a streptomycin marker. As shown in Figure 3, both
pBTC1 and pBTC2 are much more stable than
pET101 and pET104 or pET105 in E. coli JMU193
when the recombinants were grown in minimal me-
dia with hexadecanoate and yeast extract during the
tested period. The plasmids were found to be struc-
turally stable as well since the restriction patterns of
plasmid DNA isolated during the cultivation were
identical to those of the original constructs and they
allowed re-transformed JMU193 to accumulate PHA
data not shown.
PHA accumulation using alternative phaC ex-
pression systems. E. coli JMU193 containing pBTC2
yielded more PHA than JMU193 containing pET104
or pET105, as shown in Table 1. The PHA content
was increased from less than 1% without induction to
about 20% in response to induction by 100 M IPTG.
A similar behaviour was found for JMU193 carrying
pBTC1: no detectable PHA was found without induc-
tion, while about 17% PHA was formed when the re-
combinant was induced with 100 M IPTG Table 1.
Higher IPTG concentrations up to 1 mM had no ef-
fect on PHA content or PHA monomer composition
in both recombinants.
The PHA content in a host strain depends on the
precursor concentration and the polymerase concen-
tration when it is below a certain level. The precur-
sor concentration is presumably identical in E. coli
recombinants JMU193 carrying pET2, pBTC2 and
pET105. Since the PHA content Table 1 differed in
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these E. coli recombinants, these differences must be
due to the relative polymerase concentrations. The
higher amount of PHA accumulation in
JMU193pET105 about 11% of cell dry weight and
JMU193pBTC2 about 20% of cell dry weight than
that found in JMU193pET2 about 5% of cell dry
weight suggests that higher phaC gene dosage can
support the accumulation of PHA to a high concen-
tration in recombinant E. coli, which has also been
observed for poly-3-hydroxybutyrate PHB synthesis
in E. coli Lee and Chang 1995, Lee et al. 1994. In
other words, relatively large amounts of enzyme seem
to be required to direct the carbon ﬂow from 3-hy-
droxyalkanoates to PHA synthesis among the several
competing metabolic pathways such as continued ß-
oxidation Lee and Chang 1995. The reason why
JMU193pBTC1 produced less PHA about 17% of
cell dry weight than JMU193pET101 about 26%
of cell dry weight might be the higher copy number
of pET101 than pBTC1, although in both recombi-
nants, phaC1 is expressed from the strong promoters
Plac or Ptac. However, pET101 is not stable in re-
combinant E. coli Figure 3, and thus not suitable for
PHA production.
Effect of different phaC genes on the PHA com-
position. Table 1 shows that when both phaC1 and
phaC2 genes are located on the same type of plasmid,
the PHA polymers formed by PhaC1 consisted of
more C6, similar amounts of C8 and less C10 the
molar ratio of C6:C8:C10 is 10:76:14 from pET101,
11:78:11 from pBTC1, compared to polymers
produced by PhaC2 the molar ratio of C6:C8:C10 is
7:76:17 from pET105, 8:77:15 from pBTC2. The
PHA monomer composition depends on the precursor
concentration, the speciﬁcity of the PHA polymerase
for each precursor and the polymerase concentration
when it is below a certain level. The precursor con-
centration and the enzyme speciﬁcity proﬁle are pre-
sumably identical in E. coli recombinants JMU193
carrying phaC genes. Since the two genes are located
on the same type of vector, these PHA composition
differences are not likely to be due to a gene dosage
or a substrate concentration effect. Instead, these dif-
ferences suggest that the polymerases have different
substrate speciﬁcities. Evidently, PhaC1 has higher
affinity to 3-hydroxyhexanoyl-CoA and lower affinity
to 3-hydroxydecanoyl-CoA than PhaC2, as was also
found for the PHA negative mutant P. putida GPp104
carrying each of these two phaC genes Huisman et
al. 1992.
Conclusion
In this study, we investigated the expression of two
phaC genes from P. putida in E. coli. This led to the
observation that signiﬁcant PHA production in E. coli
requires high phaC1/C2 gene expression. However,
the loss of the PHA accumulation phenotype occurred
in E. coli recombinants when expression of phaC
genes was not tightly controlled, which was similar
to poly-3-hydroxybutyrate PHB production in E.
coli Lee et al. 1994. Apparently, phaC- or phbCAB-
containing plasmids are lost when they are not vital
to growth and impose detrimental effects on the cells.
Therefore, for long term PHA production in E. coli, it
is necessary to establish a system which allows stable
and high PHA production. In the present report we
generated a system where phaC expression was con-
trolled by a strong heterologous promoter from low
copy number plasmid and reached stable PHA
production in E. coli. However, the PHA levels
achieved in E. coli recombinants are not yet maximal,
compared to that in native and recombinant P. putida
where PHA is accumulated to 50-70% of cell dry
mass Huisman et al. 1992. One possibility is that the
supply of PHA precursors is rate-limiting in E. coli,
thereby limiting the attainable PHA production. Fur-
ther experiments should be done to address this pos-
sibility.
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